Clinical Trials · NCT07099742
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Dr. Md. Alimur Reza
- Enrollment
- 364
- Start date
- Sep 2025
- Locations
- 3 sites, Bangladesh
- Primary endpoint
- Percentage change in body weight at Week 24 in both treatment groups.